Tag Archives: self-management
December 2020 Br J Cardiol 2020;27(suppl 2):S2–S16 doi:10.5837/bjc2020.s05
Adapting cardiovascular disease care to the ‘new norm’ of the COVID-19 era: same standard, different delivery
Martin R Cowie, Matthew Fay, Jo Jerrome, Abhishek Joshi, Jim Moore, Helen Williams
Introduction to the steering committee From left to right: Professor Martin Cowie, Dr Matthew Fay, Ms Jo Jerrome,Dr Abhishek Joshi, Dr Jim Moore, Ms Helen Williams Conflicts of interest The steering committe received speaking and consultation fees from Bayer plc. MRC provides consultancy advice to Abbott, AstraZeneca, Bayer, Boston Scientific, Medtronic, Novartis, Roche Diagnostics and Servier. MF has received speaker honoraria, conference sponsorship, unrestricted educational grants, and/or attended meetings sponsored by AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Medtronic, Novartis, Pfizer, Roche, Sanofi-Aventis, and S
March 2015 Br J Cardiol 2015;22:38 doi:10.5837/bjc.2015.011
Optimising self-management to reduce chronic pain and disability after cardiac surgery
Michael Hugh McGillion, Andrew Turner, Sandra L Carroll, Gill Furze, Jason W Busse, Andre Lamy
Chronic pain after cardiac surgery: prevalence and impact With the growing burden of cardiovascular disease, the number of people undergoing cardiac surgery, globally, is expected to continue to rise.1 In 2010, 31,613 cardiac surgeries were performed in England and Wales,2 and prevalence data are similar in other Commonwealth countries, including Canada.2,3 While the primary aims of cardiac surgical procedures (including coronary artery bypass grafting [CABG] and valve replacement) are to improve survival, ameliorate symptoms (such as angina) and improve health-related quality of life (HRQL), mounting evidence suggests that the development of
January 2003 Br J Cardiol 2003;10:11-13
The expert patient: good thinking or a cross
Jane Flint
No content available
For healthcare professionals only
